Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compounded Rx Pr...

FDA Recall #D-0654-2024 — Class II — August 22, 2024

Recall #D-0654-2024 Date: August 22, 2024 Classification: Class II Status: Ongoing

Product Description

Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compounded Rx Product, ProRX 267-565-7008, NDC 84139-225-02

Reason for Recall

Lack of Assurance of Sterility

Recalling Firm

ProRx LLC — Exton, PA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

500 vials

Distribution

Nationwide in the USA

Code Information

Lot # ProRx031924-1, BUD 09/18/2024

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated